Polydatin alleviates mycoplasma pneumoniae-induced injury via inhibition of Caspase-1/GSDMD-dependent pyroptosis
Copyright © 2023 The Authors. Published by Elsevier GmbH.. All rights reserved..
Mycoplasma pneumoniae (MP) is one of the main pathogens causing community acquired pneumonia (CAP) in children and adults. Previous pharmacological and clinical studies have shown that Polydatin (PD) exerts anti-inflammatory action by conferring protective benefit in MP pneumonia. However, the mechanism underlying the of PD on MP infection remains unclear. It was found that PD alleviated MP-induced injury by inhibiting caspase-1/gasdermin D (GSDMD)-mediated epithelial pyroptosis. The results demonstrated that PD inhibited the transformation of GSDMD to N-terminal gasdermin-N (GSDMD-N) by decreasing caspase-1 activation, as well as suppressed the formation and secretion of interleukin-1β (IL-1β) and interleukin-18 (IL-18), reversed Na, K-ATPase reduction, and suppressed LDH release both in vitro and vivo. Taken together, epithelial pyroptosis in BEAS-2B cells and lung injury in mice were prevented by PD. In conclusion, PD suppressed pulmonary injury triggered by MP infection, by inhibiting the caspase-1/GSDMD-mediated epithelial pyroptosis signaling pathway. Thus, PD may be regarded as a potential therapy for MP-induced inflammation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:313 |
|---|---|
| Enthalten in: |
International journal of medical microbiology : IJMM - 313(2023), 5 vom: 15. Sept., Seite 151586 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chen, Yiliu [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 23.10.2023 Date Revised 23.10.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ijmm.2023.151586 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362727414 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362727414 | ||
| 003 | DE-627 | ||
| 005 | 20231226091837.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijmm.2023.151586 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1209.xml |
| 035 | |a (DE-627)NLM362727414 | ||
| 035 | |a (NLM)37776814 | ||
| 035 | |a (PII)S1438-4221(23)00014-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chen, Yiliu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Polydatin alleviates mycoplasma pneumoniae-induced injury via inhibition of Caspase-1/GSDMD-dependent pyroptosis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.10.2023 | ||
| 500 | |a Date Revised 23.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 The Authors. Published by Elsevier GmbH.. All rights reserved. | ||
| 520 | |a Mycoplasma pneumoniae (MP) is one of the main pathogens causing community acquired pneumonia (CAP) in children and adults. Previous pharmacological and clinical studies have shown that Polydatin (PD) exerts anti-inflammatory action by conferring protective benefit in MP pneumonia. However, the mechanism underlying the of PD on MP infection remains unclear. It was found that PD alleviated MP-induced injury by inhibiting caspase-1/gasdermin D (GSDMD)-mediated epithelial pyroptosis. The results demonstrated that PD inhibited the transformation of GSDMD to N-terminal gasdermin-N (GSDMD-N) by decreasing caspase-1 activation, as well as suppressed the formation and secretion of interleukin-1β (IL-1β) and interleukin-18 (IL-18), reversed Na, K-ATPase reduction, and suppressed LDH release both in vitro and vivo. Taken together, epithelial pyroptosis in BEAS-2B cells and lung injury in mice were prevented by PD. In conclusion, PD suppressed pulmonary injury triggered by MP infection, by inhibiting the caspase-1/GSDMD-mediated epithelial pyroptosis signaling pathway. Thus, PD may be regarded as a potential therapy for MP-induced inflammation | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Epithelial pyroptosis | |
| 650 | 4 | |a GSDMD | |
| 650 | 4 | |a MP | |
| 650 | 4 | |a Pneumonia | |
| 650 | 4 | |a Polydatin | |
| 650 | 7 | |a Caspase 1 |2 NLM | |
| 650 | 7 | |a EC 3.4.22.36 |2 NLM | |
| 650 | 7 | |a polydatin |2 NLM | |
| 650 | 7 | |a XM261C37CQ |2 NLM | |
| 650 | 7 | |a Intracellular Signaling Peptides and Proteins |2 NLM | |
| 650 | 7 | |a Gasdermins |2 NLM | |
| 650 | 7 | |a GSDMD protein, human |2 NLM | |
| 650 | 7 | |a Phosphate-Binding Proteins |2 NLM | |
| 650 | 7 | |a Pore Forming Cytotoxic Proteins |2 NLM | |
| 700 | 1 | |a Jiang, Yonghong |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Xiuxiu |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Xiufeng |e verfasserin |4 aut | |
| 700 | 1 | |a Fan, Qiuyue |e verfasserin |4 aut | |
| 700 | 1 | |a Xiao, Zhen |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of medical microbiology : IJMM |d 2000 |g 313(2023), 5 vom: 15. Sept., Seite 151586 |w (DE-627)NLM108811247 |x 1618-0607 |7 nnns |
| 773 | 1 | 8 | |g volume:313 |g year:2023 |g number:5 |g day:15 |g month:09 |g pages:151586 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijmm.2023.151586 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 313 |j 2023 |e 5 |b 15 |c 09 |h 151586 | ||